Efficacy and Safety of Single-Agent Ibrutinib in Patients with Mantle Cell Lymphoma Who Progressed after Bortezomib Therapy Wang, M., Goy, A., Martin, P., Ramchandren, R., Alexeeva, J., Popat, R., Avivi, I., Advani, R., Le Gouill, S., Horowitz, N., Yuan, Z., Kranenburg, B., Rizo, A., Zhuang, S., Deraedt, W., Rule, S. AMER SOC HEMATOLOGY. 2014

View details for Web of Science ID 000349233808157